My research as an in vitro pharmacologist has been to work on numerous projects involved with molecular mechanisms that underpin numerous disease states, such as nuclear receptors involved in inflammation and the use and side effects of NSAIDs. My background has been to study vasoactive compounds that control vascular function, and over the past couple of years I have worked in multi-disciplinary groups to screen for drugs that control pancreatic diseases, both diabetes and cancer. My expertise has taken me a number of interesting routes, and in collaboration with several others from Glasgow University, Lincoln University and Oxford University, we  developed a new statistical method using artificial intelligence to predict who has the virus SARS CoV2 at a very early stage of infection using only simple blood tests, and then applied these techniques to develop new prediction models for diseases. 

I am focused on improving the educational path for all students so that they may gain the career path most suited to their interests and talents. In my role of Learning and Teaching Lead for the School of Applied Sciences, I find ways to ensure there is a consistent approach taken to all aspects of assessments, ensuring transparency and parity for all. Some of my more recent research has been on how students study and engage with the large amount of content, with the aim of developing a streamlined approach to aid students.

In my teaching you will find me talking with passion about pharmacology and biochemistry, especially in Biomedical Science. I teach using primary sources of data and case studies, and make sure that students have the background knowledge so they can apply this to real world problems to solve.

A large proportion of my previous research has focused on how nuclear receptors control transcription and thus control how cells respond on the long term to pathogens and chronic disease states.
Projects on offer involve:
1. Understanding how nuclear receptors may be manipulated to ensure a rapid response to new pathogens without harming the patient
2. Changing cell function using nuclear receptor agonists to manipulate human blood derived progenitor cells to create new organs such as lung and deepening our understanding of how PPARβδ receptors control inflammation and disease. 
Two other in vitro projects in collaboration with other universities; to isolate or identify hit compounds to control diabetes and pancreatic cancer. One set of compounds have been isolated form natural plant products from Gabon (the extract is already in use to control diabetes in humans), while the other screening cascade involves compounds have been designed via computational chemistry Collaborators: Hertfordshire University and IPHAMETRA institute, Gabon.